0 Your Cart: $ 0.00
You have 0 item(s) in your cart
Total : $ 0.00
View cart Checkout
Main menu
  1. Home
  2. Corporate
  3. Newsletters

Newsletters

Favipiravir
Favipiravir
Published on: Wednesday, July 1, 2020

Favipiravir is an antiviral medication that was initially developed to treat influenza.In February 2020, post the outbreak of Novel Coronavirus (COVID..
View Newsletter | Download


Dexamethasone
Dexamethasone
Published on: Wednesday, June 24, 2020
Dexamethasone is a steroid-based medication.

Dexamethasone is a steroid-based medication.Dexamethasone, has become the subject of discussion after researchers from the Recovery Trial reported tha..
View Newsletter | Download


Doxycycline
Doxycycline
Published on: Wednesday, June 24, 2020
Doxycycline is a more generally tetracycline derivatives antibiotic with a potent antibacterial activity against a wide variety of bacteria.

Doxycycline is a more generally tetracycline derivatives antibiotic with a potent antibacterial activity against a wide variety of bacteria. Doxycycl..
View Newsletter | Download


Acyclovir
Acyclovir
Published on: Wednesday, June 17, 2020
Acyclovir is an antiviral drug. Acyclovir is used to treat infections caused by certain types of viruses.

Acyclovir is an antiviral drug. Acyclovir is used to treat infections caused by certain types of viruses. Acyclovir is under research for Covid 19 t..
View Newsletter | Download


Empagliflozin
Empagliflozin
Published on: Wednesday, June 10, 2020
Empagliflozin is an anti diabetic agent used in adult patients with type 2 diabetes mellitus.

Empagliflozin is an anti diabetic agent used in adult patients with type 2 diabetes mellitus. It was FDA-approved in 2014. It is an SGLT2 inhibitor, a..
View Newsletter | Download


Nitrosamine compounds for Metformin
Nitrosamine compounds for Metformin
Published on: Thursday, June 4, 2020
Metformin is often given as the first line of treatment for patients with Type II diabetes

The U.S. Food and Drug Administration (USFDA) has said the agency laboratory tests has revealed levels of nitrosamine impurity N-Nitrosodimethylamine ..
View Newsletter | Download


Dabrafenib D9
Dabrafenib D9
Cat No: CS-T-51570
Status: Under synthesis

Dabrafenib is a type of cancer growth blocker. It works by targeting certain proteins made by the changed BRAF gene that helps cancer cells to grow. Dabrafenib is an inhibitor of mutated BRAF kinase.
View Newsletter


Apalutamide D3
Apalutamide D3
Cat No: CS-O-32718
Status: Under synthesis

Apalutamide is a next-generation androgen receptor (AR) inhibitor which is used in the treatment of prostate cancer.
View Newsletter


Midostaurin
Midostaurin
Stable Isotopes and Metabolites
Now available

Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis. Midostaurin is now available with Clearsynth.
View Newsletter


Midostaurin
EP Standards
Category: EP standards
Now available

The European Pharmacopoeia is a major regional pharmacopoeia which provides common quality standards throughout the pharmaceutical industry to control the quality of medicines, and the substances used to manufacture them. EP standards are now available with Clearsynth at cost effective prices.
View Newsletter


Darunavir
Darunavir
Status: In stock

Darunavir is an antiviral medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection. Darunavir and it's impurities are now available e with Clearsynth.
View Newsletter